X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-04 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | P - Purchase | $4.22 | +90,525 | 7,097,340 | +1% | +$381,958 | |||||
| M | 2025-06-04 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $2.31 | -2,000 | 366,284 | -1% | -$4,613 | |||||
2025-06-05 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $19.05 | -3,377 | 129,767 | -3% | -$64,335 | ||||||
| M | 2025-06-04 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $12.34 | -200,000 | 1,450,018 | -12% | -$2,468,278 | |||||
| D | 2025-06-06 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale+OE | $64.13 | -20,000 | 63,133 | -24% | -$1,282,637 | |||||
2025-06-04 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $247.32 | -2,000 | 69,218 | -3% | -$494,640 | ||||||
2025-06-05 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | P - Purchase | $3.06 | +23,321 | 117,231 | +25% | +$71,362 | ||||||
| M | 2025-06-03 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | S - Sale | $62.16 | -75,000 | 89,363 | -46% | -$4,661,861 | |||||
2025-06-04 | OFIX | Orthofix Medical Inc. | Bazaar Alan Lee | Dir | P - Purchase | $10.92 | +2,250 | 30,983 | +8% | +$24,570 | ||||||
2025-06-03 | CLPT | Clearpoint Neuro, Inc. | Fallon Lynnette C | Dir | S - Sale | $12.57 | -10,200 | 40,901 | -20% | -$128,226 | ||||||
2025-06-04 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.58 | -10,000 | 261,491 | -4% | -$5,804 | ||||||
2025-06-04 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.66 | +8,000 | 16,222,059 | 0% | +$5,280 | ||||||
| D | 2025-06-04 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $102.88 | -56,372 | 183,576 | -23% | -$5,799,630 | |||||
2025-06-02 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $258.17 | -600 | 64,714 | -1% | -$154,903 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $17.89 | -868 | 34,132 | -2% | -$15,529 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale | $17.89 | -1,039 | 72,032 | -1% | -$18,588 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $17.89 | -1,115 | 92,904 | -1% | -$19,948 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale | $17.89 | -1,497 | 45,503 | -3% | -$26,783 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $17.89 | -3,439 | 104,561 | -3% | -$61,526 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Williamson Steven S. | Pres, CEO | S - Sale | $3.13 | -9,923 | 366,115 | -3% | -$31,059 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Joshi Mehul | CFO, PAO | S - Sale | $3.13 | -8,061 | 213,925 | -4% | -$25,231 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $3.13 | -6,947 | 386,331 | -2% | -$21,748 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $3.13 | -10,457 | 273,039 | -4% | -$32,736 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Stafford Kristin | Dir | S - Sale | $17.28 | -999 | 3,054 | -25% | -$17,259 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale | $17.31 | -999 | 81,229 | -1% | -$17,297 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Madden Martin J. | Dir | S - Sale | $17.19 | -999 | 18,674 | -5% | -$17,176 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Scannell Timothy J | Dir | S - Sale | $17.32 | -999 | 6,018 | -14% | -$17,299 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Hilleman Jeryl L | Dir | S - Sale | $17.26 | -999 | 5,591 | -15% | -$17,247 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Ocean Allyson J | Dir | S - Sale | $17.29 | -999 | 3,054 | -25% | -$17,269 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Vernon W Anthony | Dir | S - Sale | $17.35 | -999 | 167,887 | -1% | -$17,329 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Hung David | Dir | S - Sale | $17.30 | -999 | 12,195 | -8% | -$17,280 | ||||||
2025-06-02 | NVCR | Novocure Ltd | Leonard Frank X | EVP, Pres, Novocure Oncology | S - Sale | $17.50 | -30,196 | 168,452 | -15% | -$528,413 | ||||||
| M | 2025-05-30 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | P - Purchase | $3.81 | +98,782 | 6,975,863 | +1% | +$376,429 | |||||
2025-06-02 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $243.78 | -1,000 | 85,283 | -1% | -$243,780 | ||||||
| M | 2025-05-30 | MMSI | Merit Medical Systems Inc | McDonnell Michael R. | Dir | S - Sale | $94.41 | -3,500 | 6,395 | -35% | -$330,418 | |||||
2025-05-30 | MMSI | Merit Medical Systems Inc | Floyd David | Dir | S - Sale | $94.16 | -3,515 | 15,066 | -19% | -$330,972 | ||||||
| D | 2025-05-30 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P. | Pres, CEO | S - Sale+OE | $95.12 | -10,000 | 1,161,744 | -1% | -$951,200 | |||||
| D | 2025-06-02 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $103.69 | -164,443 | 1,678,360 | -9% | -$17,051,136 | |||||
2025-06-02 | IRTC | Irhythm Technologies, Inc. | Shrishrimal Sumi | EVP, Chief Risk Officer | S - Sale | $140.21 | -1,608 | 34,685 | -4% | -$225,458 | ||||||
2025-06-02 | IRTC | Irhythm Technologies, Inc. | Rosenbaum Marc W. | Chief Accounting Officer | S - Sale | $140.21 | -696 | 11,105 | -6% | -$97,586 | ||||||
2025-06-02 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $243.78 | -41 | 8,603 | 0% | -$9,995 | ||||||
2025-05-30 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $2.22 | -1,000 | 368,284 | 0% | -$2,220 | ||||||
2025-06-02 | BDX | Becton Dickinson & Co | Shan David | EVP, Chief ISC Officer | S - Sale | $171.19 | -1,166 | 4,575 | -20% | -$199,608 | ||||||
| D | 2025-05-28 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $267.91 | -16,300 | 675,871 | -2% | -$4,366,920 | |||||
2025-05-28 | ATRC | Atricure, Inc. | Doraiswamy Vinayak | Chief Scientific Officer | S - Sale | $33.44 | -2,500 | 73,550 | -3% | -$83,600 | ||||||
2025-05-29 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | S - Sale | $104.59 | -4,000 | 22,479 | -15% | -$418,368 | ||||||
2025-05-30 | ICUI | Icu Medical Inc/De | Sanzone Virginia Ruth | VP, GC | S - Sale | $133.62 | -700 | 6,386 | -10% | -$93,537 | ||||||
| M | 2025-05-27 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | P - Purchase | $3.52 | +128,189 | 6,877,081 | +2% | +$451,734 | |||||
| D | 2025-05-27 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P | Pres, CEO | S - Sale+OE | $96.54 | -20,000 | 1,171,650 | -2% | -$1,930,800 | |||||
2025-05-27 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $85.11 | -6,184 | 109,621 | -5% | -$526,318 | ||||||
2025-05-23 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $84.28 | -10,000 | 95,602 | -9% | -$842,849 | ||||||
2025-05-28 | INFU | Infusystem Holdings, Inc | Eichenbaum Kenneth D. | Dir | P - Purchase | $5.18 | +2,000 | 10,000 | +25% | +$10,360 | ||||||
| DM | 2025-05-27 | ICUI | Icu Medical Inc/De | Voigtlander Christian B. | COO | S - Sale+OE | $129.75 | -9,930 | 6,088 | -62% | -$1,288,371 | |||||
2025-05-27 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $29.00 | -8,748 | 178,510 | -5% | -$253,692 | ||||||
| A | 2025-05-23 | AORT | Artivion, Inc. | Semedo Anthony B. | Dir | S - Sale | $28.47 | -2,600 | 39,384 | -6% | -$74,027 | |||||
2025-05-23 | AORT | Artivion, Inc. | Semedo Anthony B. | Dir | S - Sale | $28.47 | -2,600 | 33,059 | -7% | -$74,027 | ||||||
2025-05-22 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $244.59 | -3,644 | 86,283 | -4% | -$891,286 | ||||||
| D | 2025-05-23 | MMM | 3M Co | Banovetz John Patrick | EVP | S - Sale+OE | $148.37 | -7,759 | 31,372 | -20% | -$1,151,237 | |||||
| A | 2023-02-02 | SYK | Stryker Corp | Berry William E Jr | VP, Chief Accounting Officer | S - Sale | $279.96 | -755 | 1,853 | -29% | -$211,370 | |||||
| DM | 2025-05-22 | ICUI | Icu Medical Inc/De | Voigtlander Christian B. | COO | S - Sale+OE | $130.02 | -9,918 | 4,903 | -67% | -$1,289,502 | |||||
2025-05-23 | EMBC | Embecta Corp. | Melcher David F | Dir | P - Purchase | $10.60 | +10,000 | 86,681 | +13% | +$105,995 | ||||||
| AM | 2025-05-20 | LUCD | Lucid Diagnostics Inc. | Matheis Dennis | Dir | P - Purchase | $1.31 | +350,000 | 565,443 | +162% | +$457,607 | |||||
| M | 2025-05-21 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.62 | -8,981 | 271,491 | -3% | -$5,596 | |||||
2025-05-20 | ICU | Seastar Medical Holding Corp | Baird Jennifer A | Dir | P - Purchase | $1.28 | +10,000 | 10,000 | New | +$12,815 | ||||||
| M | 2025-05-20 | LUCD | Lucid Diagnostics Inc. | Matheis Dennis | Dir | P - Purchase | $1.31 | +350,000 | 350,000 | New | +$457,607 | |||||
2025-05-21 | BSX | Boston Scientific Corp | Brown Vance R | SVP, GC, Corp. Secretary | S - Sale | $106.42 | -4,826 | 31,367 | -13% | -$513,583 | ||||||
2025-05-20 | RMD | Resmed Inc | De Witte Jan | Dir | S - Sale | $243.47 | -2,000 | 5,806 | -26% | -$486,940 | ||||||
2025-05-19 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $3.48 | -13,066 | 636,728 | -2% | -$45,430 | ||||||
2025-05-19 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $13.00 | -55,375 | 771,645 | -7% | -$719,875 | ||||||
2025-05-19 | TLSI | Trisalus Life Sciences, Inc. | Cox Bryan F. | CHIEF OF RESEARCH | S - Sale | $5.18 | -4,764 | 119,415 | -4% | -$24,678 | ||||||
2025-05-19 | TLSI | Trisalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Operations | S - Sale | $5.18 | -4,764 | 52,764 | -8% | -$24,678 | ||||||
2025-05-19 | TLSI | Trisalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | S - Sale | $5.18 | -6,597 | 69,101 | -9% | -$34,172 | ||||||
2025-05-19 | TLSI | Trisalus Life Sciences, Inc. | Stevens Jennifer | Chief Regulatory Officer | S - Sale | $5.18 | -8,704 | 77,640 | -10% | -$45,087 | ||||||
| DM | 2025-05-20 | ICUI | Icu Medical Inc/De | Voigtlander Christian B. | COO | S - Sale+OE | $135.05 | -9,788 | 3,711 | -73% | -$1,321,840 | |||||
2025-05-19 | ALUR | Allurion Technologies, Inc. | Gaur Shantanu | CEO | P - Purchase | $3.06 | +8,000 | 78,032 | +11% | +$24,484 | ||||||
| M | 2025-05-19 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.66 | -11,019 | 280,472 | -4% | -$7,306 | |||||
2025-05-19 | INSP | Inspire Medical Systems, Inc. | Rondoni John | See Remarks | S - Sale | $149.38 | -1,734 | 13,766 | -11% | -$259,025 | ||||||
| D | 2025-05-20 | MMM | 3M Co | Rhodes Kevin H | EVP, Chief Legal Off, Secret | S - Sale+OE | $154.02 | -7,976 | 15,147 | -34% | -$1,228,464 | |||||
2025-05-21 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $29.00 | -9,926 | 187,258 | -5% | -$287,854 | ||||||
2025-05-16 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $2.58 | -1,000 | 369,284 | 0% | -$2,575 | ||||||
| M | 2025-05-16 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $19.62 | -17,797 | 793,945 | -2% | -$349,134 | |||||
| M | 2025-05-16 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $19.70 | -12,009 | 222,083 | -5% | -$236,612 | |||||
2025-05-16 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $19.56 | -4,147 | 282,431 | -1% | -$81,109 | ||||||
2025-05-16 | SIBN | Si-Bone, Inc. | Pisetsky Michael A | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $19.66 | -3,459 | 264,808 | -1% | -$68,006 | ||||||
| DM | 2025-05-16 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale+OE | $85.57 | -100,000 | 1,827,003 | -5% | -$8,556,631 | |||||
2025-05-20 | ICU | Seastar Medical Holding Corp | Chung Kevin | Chief Medical Officer | P - Purchase | $1.25 | +4,500 | 18,185 | +33% | +$5,625 | ||||||
| D | 2025-05-19 | INFU | Infusystem Holdings, Inc | Hundzinski Ronald T | Dir | P - Purchase | $6.09 | +5,000 | 5,000 | New | +$30,450 | |||||
| M | 2025-05-15 | PROF | Profound Medical Corp. | Menawat Arun Swarup | CEO | P - Purchase | $4.55 | +22,030 | 587,089 | +4% | +$100,151 | |||||
2025-05-19 | ICUI | Icu Medical Inc/De | Finney Elisha W | Dir | S - Sale | $138.92 | -600 | 3,252 | -16% | -$83,353 | ||||||
| D | 2025-05-15 | MMSI | Merit Medical Systems Inc | Millner F. Ann | Dir | S - Sale+OE | $96.47 | -21,250 | 34,543 | -38% | -$2,049,988 | |||||
2025-05-15 | CVRX | Cvrx, Inc. | Nielsen Kirk G. | Dir | P - Purchase | $5.45 | +10,966 | 1,910,134 | +1% | +$59,795 | ||||||
| DM | 2025-05-16 | ICUI | Icu Medical Inc/De | Voigtlander Christian B. | COO | S - Sale+OE | $139.00 | -11,110 | 2,389 | -82% | -$1,544,314 | |||||
2025-05-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +5,665 | 16,214,059 | 0% | +$4,151 | ||||||
| D | 2025-05-15 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $149.02 | -7,915 | 6,422 | -55% | -$1,179,469 | |||||
| M | 2025-05-15 | INFU | Infusystem Holdings, Inc | Lachance Carrie | Pres, COO | P - Purchase | $6.06 | +3,132 | 377,292 | +1% | +$18,987 | |||||
| D | 2025-05-14 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $298.22 | -16,600 | 924,195 | -2% | -$4,950,476 | |||||
2025-05-15 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $286.15 | -100 | 5,423 | -2% | -$28,615 | ||||||
2025-05-14 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $15.85 | -168,136 | 3,238,199 | -5% | -$2,665,333 | ||||||
| D | 2025-05-15 | SNWV | Sanuwave Health, Inc. | Cioanta Iulian | Chief Sci., Tech. Officer | S - Sale+OE | $31.60 | -3,639 | 41 | -99% | -$114,992 | |||||
2025-05-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.75 | +86,014 | 16,208,394 | +1% | +$64,846 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |